BRPI1010911A2 - "anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus" - Google Patents

"anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus"

Info

Publication number
BRPI1010911A2
BRPI1010911A2 BRPI1010911A BRPI1010911A BRPI1010911A2 BR PI1010911 A2 BRPI1010911 A2 BR PI1010911A2 BR PI1010911 A BRPI1010911 A BR PI1010911A BR PI1010911 A BRPI1010911 A BR PI1010911A BR PI1010911 A2 BRPI1010911 A2 BR PI1010911A2
Authority
BR
Brazil
Prior art keywords
epitope
antibodies
fragments
directed against
staphylococcus aureus
Prior art date
Application number
BRPI1010911A
Other languages
English (en)
Portuguese (pt)
Inventor
Dr Udo Lorenz
Knut Ohlsen
Original Assignee
Julius Maximilians Univ Wuerzburg De/De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Julius Maximilians Univ Wuerzburg De/De filed Critical Julius Maximilians Univ Wuerzburg De/De
Publication of BRPI1010911A2 publication Critical patent/BRPI1010911A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
BRPI1010911A 2009-05-18 2010-05-18 "anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus" BRPI1010911A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17913309P 2009-05-18 2009-05-18
PCT/EP2010/056827 WO2010133600A1 (en) 2009-05-18 2010-05-18 Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab

Publications (1)

Publication Number Publication Date
BRPI1010911A2 true BRPI1010911A2 (pt) 2019-09-24

Family

ID=42316060

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010911A BRPI1010911A2 (pt) 2009-05-18 2010-05-18 "anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus"

Country Status (13)

Country Link
US (3) US8609102B2 (enExample)
EP (1) EP2432804B1 (enExample)
JP (2) JP5882892B2 (enExample)
CN (1) CN102695724B (enExample)
AU (1) AU2010251156C1 (enExample)
BR (1) BRPI1010911A2 (enExample)
CA (1) CA2761886A1 (enExample)
ES (1) ES2537437T3 (enExample)
MX (1) MX2011012248A (enExample)
PL (1) PL2432804T3 (enExample)
PT (1) PT2432804E (enExample)
RU (1) RU2560415C2 (enExample)
WO (1) WO2010133600A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5882892B2 (ja) * 2009-05-18 2016-03-09 ユリウス・マクシミリアンス−ウニヴェルジテート・ヴュルツブルクＪｕｌｉｕｓ Ｍａｘｉｍｉｌｉａｎｓ−Ｕｎｉｖｅｒｓｉｔａｅｔ Ｗｕｅｒｚｂｕｒｇ 黄色ブドウ球菌エピトープＩｓａＡまたはＩｓａＢに対する抗体またはそれらのフラグメント
WO2013041707A1 (en) 2011-09-23 2013-03-28 Julius-Maximilians-Universität Würzburg Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site
US9944694B2 (en) 2013-12-13 2018-04-17 Rijksuniversiteit Groningen Antibodies against Staphylococcus aureus and uses therof
CN119176871A (zh) 2018-07-24 2024-12-24 免疫医疗有限责任公司 抗金黄色葡萄球菌凝集因子a(clfa)的抗体
KR102341805B1 (ko) * 2019-11-27 2021-12-22 주식회사 하울바이오 황색포도상구균에 특이적으로 반응하는 항-IsaA G4 항체 및 이의 용도
KR102341804B1 (ko) * 2019-11-27 2021-12-22 주식회사 하울바이오 황색포도상구균을 억제하는 항-IsaA F10 항체 및 이의 용도
US20230357373A1 (en) * 2019-12-17 2023-11-09 Mie University Methods and compositions for evaluating and treating fibrosis
WO2022250205A1 (ko) * 2021-05-25 2022-12-01 주식회사 하울바이오 항-IsaA F10 항체의 아토피 피부염 예방 및 개선 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4238806A1 (en) * 1991-11-18 1993-05-27 Dainabot Co Methicillin-resistant staphylococcus aureus (MRSA)detection method - by detection of MRSA penicillin binding protein (PBP)2 antigen-antibody complex, and synthetic MRSA PBP2 peptides
FR2746398B1 (fr) * 1996-03-21 1998-04-30 Bio Merieux Anticorps specifique de staphylococcus aureaus, et utilisations
RU2144190C1 (ru) * 1998-01-13 2000-01-10 Катханов Али Муратович Способ диагностики стафилококковой инфекции
GB0014907D0 (en) * 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
KR20070104590A (ko) * 2005-01-10 2007-10-26 나비 바이오파마슈티컬즈 스타필로코쿠스 아우레우스 감염을 치료하는 방법
JP5882892B2 (ja) * 2009-05-18 2016-03-09 ユリウス・マクシミリアンス−ウニヴェルジテート・ヴュルツブルクＪｕｌｉｕｓ Ｍａｘｉｍｉｌｉａｎｓ−Ｕｎｉｖｅｒｓｉｔａｅｔ Ｗｕｅｒｚｂｕｒｇ 黄色ブドウ球菌エピトープＩｓａＡまたはＩｓａＢに対する抗体またはそれらのフラグメント

Also Published As

Publication number Publication date
US20120100151A1 (en) 2012-04-26
JP2016047828A (ja) 2016-04-07
RU2011146424A (ru) 2013-06-27
WO2010133600A1 (en) 2010-11-25
EP2432804B1 (en) 2015-02-25
PL2432804T3 (pl) 2015-08-31
US20160109449A1 (en) 2016-04-21
JP2012527423A (ja) 2012-11-08
AU2010251156A1 (en) 2011-11-24
RU2560415C2 (ru) 2015-08-20
US9658230B2 (en) 2017-05-23
CA2761886A1 (en) 2010-11-25
MX2011012248A (es) 2012-02-29
US9260511B2 (en) 2016-02-16
EP2432804A1 (en) 2012-03-28
ES2537437T3 (es) 2015-06-08
US20140072570A1 (en) 2014-03-13
AU2010251156C1 (en) 2015-02-05
US8609102B2 (en) 2013-12-17
JP5882892B2 (ja) 2016-03-09
CN102695724A (zh) 2012-09-26
CN102695724B (zh) 2016-08-24
PT2432804E (pt) 2015-06-25
AU2010251156B2 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
SMT201600117B (it) Composizioni per l'immunizzazione contro staphylococcus aureus
BRPI1010911A2 (pt) "anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus"
IL217084A0 (en) Immunogenic compositions of staphylococcus aureus antigens
BRPI1015540A2 (pt) ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
EP2332698A4 (en) ROBOT HAND
BRPI1010909A2 (pt) "inseticida arilpirrolinas"
BR112013016153A2 (pt) composições imunogênicas estáveis de antígenos de staphylococcus aureus
EP2380713A4 (en) ROBOT HAND
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
PT2170388T (pt) Formulações de anticorpos anti-cd20
EP2382734A4 (en) VERIFICATION OF SOFTWARE APPLICATIONS
BRPI1010625A2 (pt) "composições de pesticida incluindo adjuvantes poliméricos"
EP2383082A4 (en) ROBOT HAND
BRPI0924425A2 (pt) "combinações de substâncias ativas sinergéticas".
BR112014004782A2 (pt) formulações adjuvantes de antígenos de staphylococcus aureus
EP2634199A4 (en) (Meth) acrylate composition
EP2606251A4 (en) VISKÖSE CLUTCH VALVE ASSEMBLY
BRPI1009984A2 (pt) "válvula de diafragma"
EP2756034A4 (en) THERMOPLASTIC STRENGTH COMPOSITION FROM AGRICULTURAL WASTE
BR112014025299A8 (pt) anticorpo de reação cruzada dirigido contra staphylococcus aureus, preparação farmacêutica e diagnóstica compreendendo o anticorpo, métodos de anticorpo de reação cruzada contra staphylococcus aureus
BRPI1014455A2 (pt) "luva de fraturação universal"
FR2934751B1 (fr) Tondeuse de type autoportee
EP2872155A4 (en) BIOMATERIALS FOR IMPROVED IMPLANT HOST INTEGRATION
EP2593103A4 (en) Reducing transmission of sexually transmitted infections
EP2545899A4 (en) COMPOSITIONS TO THE PROPHYLAXIS OF CANDIDOSIS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.